Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Case Report

Case Study Case Rep. 2011; 1(3): 137-145


Long-Term Stable Disease of Stage IV Pancreatic Neuroendocrine Tumors and Without Significant Adverse Effect by CPI-613, an Investigational Novel Anti-Cancer Agent

King Lee; Divis Khaira; Robert Rodriguez; Claudia Maturo; Kathleen O&’Donnell; Robert Shorr.

Abstract
Introduction: The current case study describes the safety and prolonged therapeutic effect of an investigational drug (CPI-613) in a patient (Patient LRW) with Stage IV pancreatic neuroendocrine tumors.

Case presentation: Patient LRW was an 88-year old Caucasian woman who was diagnosed with pancreatic neuroendocrine tumors, and had been treated with Sandostatin followed by Enzastaurin. Prior to treatment with CPI-613, she was suffering from progressive Stage IV disease, with lesions located in multiple areas including the pancreas, liver, lung, uterine, stomach, thyroid nodule, etc. During the one-year treatment with CPI-613, only two incidents of mild (Grade 1) and transient adverse events (metallic taste and hyperuricemia) were observed. The Progression-Free Survival was >15 months (Patient LRW still alive as of June 2011), which is consistent with the reported median Progression-Free Survival of 11.4 months with Everolimus treatment and 11.4-12.6 months with Sunitinib treatment. Since the disease remained stable for a year during treatment with CPI-613, Patient LRW was switched to maintenance therapy with CPI-613 and is currently doing well.

Conclusion: In Patient LRW, who had Stage IV pancreatic neuroendocrine tumor with Disease Progression, CPI-613 therapy provided long-term Stable Disease and with only 2 minor transient incidents of adverse events during a one-year treatment. This is an uncommon case where chemotherapy with an investigational drug is providing long-term stabilization of advanced metastatic disease without significant adverse events.

Key words: pancreatic neuroendocrine tumors;CPI-613



Share this Article


Advertisement
Archives of Clinical and Experimental Surgery (ACES)

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons